08/14/2025
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2025
7:01 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
7:31 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
2:15 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form DEF 14A | |
05/05/2025
3:35 PM | Cocrystal Pharma (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for COCP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cocrystal Pharma and its competitors with MarketBeat's FREE daily newsletter. |
04/25/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form PRE 14A | |
04/24/2025
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
3:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
2:30 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
7:30 AM | Cocrystal Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
8:10 AM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Hassan Fred (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Japour Anthony J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Martin James Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
PFENNIGER RICHARD C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Lee Sam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:05 PM | Cocrystal Pharma (Issuer)
Rubin Steven D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:06 PM | Cocrystal Pharma (Issuer)
FROST PHILLIP MD ET AL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
3:06 PM | Cocrystal Pharma (Issuer)
Kornberg Roger D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
4:02 PM | Cocrystal Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
MarketBeat All Access